Gevo (NASDAQ:GEVO) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday. The firm presently has a $0.75 price target on the energy company’s stock. Zacks Investment Research‘s price target would indicate a potential upside of 17.19% from the company’s current price.
According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “
Several other brokerages have also recently commented on GEVO. HC Wainwright restated a “buy” rating and set a $12.00 target price on shares of Gevo in a report on Wednesday, October 4th. ValuEngine cut shares of Gevo from a “sell” rating to a “strong sell” rating in a report on Thursday, November 9th.
Gevo (NASDAQ:GEVO) last announced its earnings results on Monday, November 6th. The energy company reported ($0.36) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.05. Gevo had a negative net margin of 84.42% and a negative return on equity of 40.58%. The business had revenue of $7.70 million during the quarter, compared to analysts’ expectations of $5.49 million. equities research analysts predict that Gevo will post -1.69 EPS for the current year.
A hedge fund recently raised its stake in Gevo stock. Virtu KCG Holdings LLC boosted its position in shares of Gevo, Inc. (NASDAQ:GEVO) by 557.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 182,390 shares of the energy company’s stock after acquiring an additional 154,654 shares during the quarter. Virtu KCG Holdings LLC owned 1.21% of Gevo worth $126,000 at the end of the most recent reporting period. 7.07% of the stock is owned by hedge funds and other institutional investors.
Gevo, Inc (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.